EW · NYSE · Medical - Devices

Edwards Lifesciences

Builds catheter-based and surgical heart-valve systems led by the SAPIEN TAVR platform.

$91.14
After-hours close+0.94 (+1.04%)
At close$90.20(+0.28%)
DateEstimateReportedSurprise
Oct 2026$0.73
Jul 2026$0.74$0.78+5.0%
Apr 2026$0.73$0.78+7.0%
Feb 2026$0.62$0.58−6.1%
Oct 2025$0.60$0.67+12.4%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 2025
Apr 2025
Feb 2025
Oct 2024
Jul 2024
Apr 2024
Feb 2024
Oct 2023
Jul 2023
Apr 2023
Jan 2023
Oct 2022
Jul 2022
Apr 2022
Jan 2022
Oct 2021
Jul 2021
Apr 2021
Jan 2021
Oct 2020
Jul 2020
Apr 2020
Jan 2020
Oct 2019
Jul 2019
Apr 2019
Jan 2019
Oct 2018
Jul 2018
Apr 2018
Feb 2018
Oct 2017
Jul 2017
Apr 2017
Feb 2017
Oct 2016
Jul 2016
Apr 2016
Feb 2016
Oct 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 29, 2026$0.73$1.68B
Jul 23, 2026$0.74$0.78+5.0%$1.70B$1.74B+2.4%
Apr 23, 2026$0.73$0.78+7.0%$1.60B$1.65B+3.2%
Feb 10, 2026$0.62$0.58−6.1%$1.55B$1.57B+1.5%
Oct 30, 2025$0.60$0.67+12.4%$1.50B$1.55B+3.7%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 24, 2025
Apr 23, 2025
Feb 11, 2025
Oct 24, 2024
Jul 24, 2024
Apr 25, 2024
Feb 6, 2024
Oct 25, 2023
Jul 26, 2023
Apr 26, 2023
Jan 31, 2023
Oct 27, 2022
Jul 28, 2022
Apr 26, 2022
Jan 26, 2022
Oct 27, 2021
Jul 29, 2021
Apr 20, 2021
Jan 27, 2021
Oct 21, 2020
Jul 23, 2020
Apr 23, 2020
Jan 30, 2020
Oct 23, 2019
Jul 23, 2019
Apr 23, 2019
Jan 31, 2019
Oct 23, 2018
Jul 26, 2018
Apr 24, 2018
Feb 1, 2018
Oct 24, 2017
Jul 26, 2017
Apr 25, 2017
Feb 1, 2017
Oct 25, 2016
Jul 26, 2016
Apr 26, 2016
Feb 2, 2016
Oct 26, 2015
Jul 28, 2015